Tilray Brands, Inc. (TLRY) vs YD Bio Limited Ordinary Shares (YDES)

A side-by-side comparison of Tilray Brands, Inc. and YD Bio Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

TLRY

Tilray Brands, Inc.

$423M

$3.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

YDES

YD Bio Limited Ordinary Shares

$436M

$6.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — TLRY vs YDES

growth of $100 · dividends reinvested · last 1y

TLRY -41.5% (-41.5%/yr)YDES -40.9% (-40.9%/yr)YDES compounded faster over this window

TLRY YDES

TLRY vs YDES: by the numbers

•YDES is the larger company ($436M vs $423M market cap).
•Both run net losses; TLRY's is the smaller (-12.90% vs -1392.61% net margin).

Metrics side by side

Valuation

Metric	TLRY	YDES
P/S ratio	0.37	N/A
P/B ratio	0.26	N/A
EV / EBITDA	22.89	N/A

Profitability

Metric	TLRY	YDES
Gross margin	27.57%	-7.06%
Operating margin	-5.18%	-883.31%
Net margin	-12.90%	-1392.61%
ROE	-9.23%	-66.49%
ROIC	-2.98%	N/A

Growth (annualized)

Metric	TLRY	YDES
Revenue CAGR (5Y)	17.11%	N/A
Total return CAGR (5Y)	-49.30%	N/A

Go deeper

Full TLRY analysis Full YDES analysis Interactive comparison tool

Dig into the metrics

Tilray Brands ROE YD Bio Limited Ordinary Shares ROE Tilray Brands operating margin YD Bio Limited Ordinary Shares operating margin Tilray Brands revenue growth YD Bio Limited Ordinary Shares revenue growth Tilray Brands free cash flow YD Bio Limited Ordinary Shares free cash flow

Tilray Brands & YD Bio Limited Ordinary Shares appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.